603858 步长制药
已收盘 07-08 15:00:00
资讯
新帖
简况
每周股票复盘:步长制药(603858)泸州步长拟增资3.2亿引资
证券之星 · 07-05
每周股票复盘:步长制药(603858)泸州步长拟增资3.2亿引资
步长制药(603858)披露控股子公司泸州步长拟增资扩股并发行可转债事项,6月29日股价上涨5.85%
证券之星 · 06-29
步长制药(603858)披露控股子公司泸州步长拟增资扩股并发行可转债事项,6月29日股价上涨5.85%
每周股票复盘:步长制药(603858)完成近1.5亿回购
证券之星 · 06-28
每周股票复盘:步长制药(603858)完成近1.5亿回购
步长制药(603858)披露2025年年度股东会决议公告,6月26日股价下跌4.14%
证券之星 · 06-26
步长制药(603858)披露2025年年度股东会决议公告,6月26日股价下跌4.14%
步长制药(603858)披露股份回购实施结果暨股份变动公告,6月22日股价下跌1.11%
证券之星 · 06-22
步长制药(603858)披露股份回购实施结果暨股份变动公告,6月22日股价下跌1.11%
步长制药:累计回购公司股份9821996股
证券日报网 · 06-22
步长制药:累计回购公司股份9821996股
步长制药(603858)披露2025年年度股东会会议资料,6月17日股价下跌1.35%
证券之星 · 06-17
步长制药(603858)披露2025年年度股东会会议资料,6月17日股价下跌1.35%
破发股步长制药跌1.35% 2016上市募39亿中信证券保荐
中金财经 · 06-17
破发股步长制药跌1.35% 2016上市募39亿中信证券保荐
股市必读:步长制药(603858)6月16日董秘有最新回复
证券之星 · 06-17
股市必读:步长制药(603858)6月16日董秘有最新回复
步长制药:通过动态调整子公司布局提升运营效率
证券之星 · 06-16
步长制药:通过动态调整子公司布局提升运营效率
步长制药:公司目前经营情况正常,业绩总体向好
证券之星 · 06-16
步长制药:公司目前经营情况正常,业绩总体向好
步长制药:注射用依派促红素α、阿达木单抗注射液上市审评审批中
证券之星 · 06-16
步长制药:注射用依派促红素α、阿达木单抗注射液上市审评审批中
步长制药:公司目前已批准的产品中,和减肥相关的产品有轻身减肥片
证券之星 · 06-16
步长制药:公司目前已批准的产品中,和减肥相关的产品有轻身减肥片
每周股票复盘:步长制药(603858)首次回购股份197万
证券之星 · 06-07
每周股票复盘:步长制药(603858)首次回购股份197万
步长制药(603858)披露以集中竞价交易方式回购股份的回购报告书,6月1日股价上涨1.54%
证券之星 · 06-01
步长制药(603858)披露以集中竞价交易方式回购股份的回购报告书,6月1日股价上涨1.54%
步长制药(603858)披露拟转让控股子公司部分股权及放弃优先受让权进展,5月29日股价上涨1.08%
证券之星 · 05-29
步长制药(603858)披露拟转让控股子公司部分股权及放弃优先受让权进展,5月29日股价上涨1.08%
步长制药(603858)披露为控股子公司提供担保公告,5月28日股价下跌1.93%
证券之星 · 05-28
步长制药(603858)披露为控股子公司提供担保公告,5月28日股价下跌1.93%
步长制药(603858)披露召开2025年年度股东会的通知,5月25日股价上涨0.2%
证券之星 · 05-25
步长制药(603858)披露召开2025年年度股东会的通知,5月25日股价上涨0.2%
每周股票复盘:步长制药(603858)控股子公司签署1200万流感疫苗许可协议
证券之星 · 05-24
每周股票复盘:步长制药(603858)控股子公司签署1200万流感疫苗许可协议
步长制药(603858)披露控股子公司拟签署知识产权合作协议的进展公告,5月19日股价上涨0.58%
证券之星 · 05-19
步长制药(603858)披露控股子公司拟签署知识产权合作协议的进展公告,5月19日股价上涨0.58%
加载更多
公司概况
公司名称:
山东步长制药股份有限公司
所属行业:
医药制造业
上市日期:
2016-11-18
主营业务:
山东步长制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是脑心通胶囊、稳心颗粒、丹红注射液、妇科用药、前列舒通胶囊、宣肺败毒颗粒、复方脑肽节苷脂注射液、复方曲肽注射液、谷红注射液、银杏蜜环口服溶液、生物药、流感病毒裂解疫苗、四价流感病毒裂解疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗。公司名列“2023年度中国中药企业TOP100排行榜”第四位。
发行价格:
55.88
{"stockData":{"symbol":"603858","market":"SH","secType":"STK","nameCN":"步长制药","latestPrice":15.75,"timestamp":1783494001000,"preClose":15.15,"halted":0,"volume":9769617,"delay":0,"changeRate":0.0396,"floatShares":1055000000,"shares":1055000000,"eps":0.3546,"marketStatus":"已收盘","change":0.6,"latestTime":"07-08 15:00:00","open":15.13,"high":15.79,"low":14.91,"amount":151000000,"amplitude":0.0581,"askPrice":15.75,"askSize":443,"bidPrice":15.74,"bidSize":6917,"shortable":0,"etf":0,"ttmEps":0.3546,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783560600000},"marketStatusCode":5,"adr":0,"adjPreClose":15.15,"symbolType":"stock","openAndCloseTimeList":[[1783474200000,1783481400000],[1783486800000,1783494000000]],"highLimit":16.67,"lowLimit":13.64,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1054568442,"isCdr":false,"pbRate":1.63,"roa":"--","peRate":44.416244,"roe":"3.16%","epsLYR":0.3416,"committee":0.653981,"marketValue":16609000000,"turnoverRate":0.0093,"status":0,"floatMarketCap":16609000000},"requestUrl":"/m/hq/s/603858","defaultTab":"news","newsList":[{"id":"2649692690","title":"每周股票复盘:步长制药(603858)泸州步长拟增资3.2亿引资","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649692690?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:42","pubTimestamp":1783194131,"startTime":"0","endTime":"0","summary":"公司公告汇总:评估报告显示,截至2026年5月31日,泸州步长股东全部权益评估值为382,635.31万元。公司公告汇总山东步长制药股份有限公司控股子公司泸州步长拟通过增资扩股引入外部投资者,合计增资3.2亿元,同时发行5,000万元可转债。公司放弃优先认购权,持股比例由97.9545%降至90.3464%,泸州步长仍为公司控股子公司。公司对泸州步长本次股权增资承担回购义务,并为可转债还款付息提供担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370551","title":"步长制药(603858)披露控股子公司泸州步长拟增资扩股并发行可转债事项,6月29日股价上涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647370551?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:21","pubTimestamp":1782742874,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,步长制药报收于15.21元,较前一交易日上涨5.85%,最新总市值为160.4亿元。该股当日开盘14.38元,最高15.27元,最低14.01元,成交额达1.26亿元,换手率为0.81%。近日,山东步长制药股份有限公司发布第五届董事会第五十一次会议决议公告。上述事项涉及关联交易,关联董事已回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646130243","title":"每周股票复盘:步长制药(603858)完成近1.5亿回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2646130243","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646130243?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:55","pubTimestamp":1782586509,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,步长制药报收于14.37元,较上周的15.28元下跌5.96%。本周,步长制药6月24日盘中最高价报15.65元。山东步长制药股份有限公司于2026年6月26日召开2025年年度股东会,会议由董事王新主持,采用现场与网络投票结合方式召开,出席股东所持表决权股份占公司总股本的61.9693%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646659903","title":"步长制药(603858)披露2025年年度股东会决议公告,6月26日股价下跌4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646659903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646659903?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:38","pubTimestamp":1782484700,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,步长制药报收于14.37元,较前一交易日下跌4.14%,最新总市值为151.54亿元。近日,山东步长制药股份有限公司披露《2025年年度股东会决议公告》。公告显示,公司于2026年6月26日召开2025年年度股东会,会议由董事王新主持,采用现场与网络投票结合方式召开,出席股东所持表决权股份占公司总股本的61.9693%。其中部分议案为特别决议及涉及关联交易,已按规定回避表决并获有效通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073411","title":"步长制药(603858)披露股份回购实施结果暨股份变动公告,6月22日股价下跌1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073411","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645073411?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:39","pubTimestamp":1782139157,"startTime":"0","endTime":"0","summary":"近日,山东步长制药股份有限公司发布《关于股份回购实施结果暨股份变动的公告》。公告显示,公司于2026年5月25日召开董事会,审议通过以集中竞价交易方式回购股份的方案,回购期限为董事会审议通过后12个月内,回购价格上限为21.00元/股,预计回购金额为7,500万元至15,000万元。回购股份存放于公司回购专用证券账户,拟用于员工持股计划或股权激励、转换公司可转债。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645107352","title":"步长制药:累计回购公司股份9821996股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645107352","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645107352?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:01","pubTimestamp":1782136860,"startTime":"0","endTime":"0","summary":"证券日报网讯6月22日,步长制药发布公告称,公司通过集中竞价交易方式已累计回购公司股份9,821,996股,已回购股份占公司总股本的比例为0.93%,购买的最高价为15.64元/股,最低价为14.42元/股,累计已支付的总金额为149,877,648.98元(含交易费用)。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-22/doc-inieiatk0081353.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-22/doc-inieiatk0081353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644742442","title":"步长制药(603858)披露2025年年度股东会会议资料,6月17日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644742442?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:50","pubTimestamp":1781707826,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘,步长制药报收于15.39元,较前一交易日下跌1.35%,最新总市值为162.3亿元。该股当日开盘15.57元,最高15.66元,最低15.25元,成交额达5769.3万元,换手率为0.36%。近日,山东步长制药股份有限公司发布2025年年度股东会会议资料。公司2025年实现营业收入118.75亿元,归属于母公司净利润3.61亿元。同时披露2026年度财务预算,预计营业收入135.18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644711350","title":"破发股步长制药跌1.35% 2016上市募39亿中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2644711350","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644711350?lang=zh_cn&edition=full","pubTime":"2026-06-17 16:19","pubTimestamp":1781684344,"startTime":"0","endTime":"0","summary":"中国经济网北京6月17日讯 步长制药 今日收报15.39元,跌幅1.35%。目前该股处于破发状态。 步长制药在2016年11月18日登陆上交所,发行数量为6,980万股,无老股转让,发行价为55.88元。 步长制药本次发行募集资金总额390,042.40万元,扣除发行费用后的募集资金净额为367,143.57万元。 步长制药本次公开发行新股的发行费用合计22,898.83万元,其中中信证券获得承销和保荐费用21,974.80万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260617/32282498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","LU1781817850.SGD","LU2289578879.USD","BK0239","BK0276","BK0012","BK1516","IPOS","LU1997245177.USD","LU1997244956.HKD","LU1255011170.USD","LU1580142542.USD","LU1655091616.SGD","BK0196","LU1794554557.SGD","06030","LU1720050803.USD","600030","BK1521","BK0188","BK1564","LU1064130708.USD","LU1064131003.USD","LU1997245094.SGD","LU2148510915.USD","BK1147","LU2495084118.USD","LU1328615791.USD","603858","BK0183","LU0405327148.USD","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644764662","title":"股市必读:步长制药(603858)6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644764662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644764662?lang=zh_cn&edition=full","pubTime":"2026-06-17 02:03","pubTimestamp":1781632994,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,步长制药报收于15.6元,上涨0.39%,换手率0.54%,成交量5.71万手,成交额8847.65万元。公司目前已批准的产品中,和减肥相关的产品有轻身减肥片。投资者: 公司的创新药促红素和阿达木单抗注射液2026年能否获批上市.董秘: 尊敬的投资者您好,感谢您对公司的关注。截至2025年末,注射用依派促红素α、阿达木单抗注射液的研发所处阶段为上市审评审批中,后续如有进展以公司公告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700000800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643975339","title":"步长制药:通过动态调整子公司布局提升运营效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2643975339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643975339?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:48","pubTimestamp":1781603300,"startTime":"0","endTime":"0","summary":"证券之星消息,步长制药06月16日在投资者关系平台上答复投资者关心的问题。公司联合相关业务人员设立控股子公司,布局医疗器械销售、药品零售等领域,旨在完善大健康产业链,并通过风险共担与利益绑定机制强化核心团队激励。同时,基于优化资源配置、降低管理成本的考虑,对部分子公司进行注销或股权转让。通过动态调整子公司布局,集中资源聚焦核心优势领域,有助于提升整体运营效率和管理效能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600032191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643753366","title":"步长制药:公司目前经营情况正常,业绩总体向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2643753366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643753366?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:48","pubTimestamp":1781603298,"startTime":"0","endTime":"0","summary":"证券之星消息,步长制药(603858)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问:购买你的股票的股民在流血,涛哥看不到么?这背后是多少个家庭?步长制药回复:尊敬的投资者您好,感谢您的关注。公司目前经营情况正常,业绩总体向好,并通过分红、回购回报投资者。股价波动受宏观经济、行业政策、市场情绪等多重因素影响,公司将持续优化产品结构,提升核心竞争力,推动长期价值增长。谢谢。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600032188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643753313","title":"步长制药:注射用依派促红素α、阿达木单抗注射液上市审评审批中","url":"https://stock-news.laohu8.com/highlight/detail?id=2643753313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643753313?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:48","pubTimestamp":1781603298,"startTime":"0","endTime":"0","summary":"证券之星消息,步长制药(603858)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的创新药促红素和阿达木单抗注射液2026年能否获批上市.步长制药回复:尊敬的投资者您好,感谢您对公司的关注。截至2025年末,注射用依派促红素α、阿达木单抗注射液的研发所处阶段为上市审评审批中,后续如有进展以公司公告为准。谢谢。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600032189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643753326","title":"步长制药:公司目前已批准的产品中,和减肥相关的产品有轻身减肥片","url":"https://stock-news.laohu8.com/highlight/detail?id=2643753326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643753326?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:48","pubTimestamp":1781603287,"startTime":"0","endTime":"0","summary":"证券之星消息,步长制药(603858)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司有在售跟在研的减肥药吗步长制药回复:尊敬的投资者您好,感谢您的关注。公司目前已批准的产品中,和减肥相关的产品有轻身减肥片。该产品暂未生产销售,谢谢。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600032179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641412759","title":"每周股票复盘:步长制药(603858)首次回购股份197万","url":"https://stock-news.laohu8.com/highlight/detail?id=2641412759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641412759?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:17","pubTimestamp":1780769830,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘,步长制药报收于15.05元,较上周的14.93元上涨0.8%。山东步长制药股份有限公司关于以集中竞价交易方式首次回购股份的公告公司于2026年6月2日首次通过集中竞价交易方式回购股份1,974,600股,占公司总股本的0.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995071","title":"步长制药(603858)披露以集中竞价交易方式回购股份的回购报告书,6月1日股价上涨1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995071","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640995071?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:43","pubTimestamp":1780324997,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,步长制药报收于15.16元,较前一交易日上涨1.54%,最新总市值为159.87亿元。近日,山东步长制药股份有限公司披露《关于以集中竞价交易方式回购股份的回购报告书》。公告显示,公司拟以集中竞价交易方式回购股份,回购金额为0.75亿元至1.50亿元,资金来源为公司自有资金及金融机构回购专项借款,其中自有资金不低于回购总额的10%。回购股份价格不超过21.00元/股,回购期限为董事会审议通过之日起不超过十二个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639267371","title":"步长制药(603858)披露拟转让控股子公司部分股权及放弃优先受让权进展,5月29日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639267371","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639267371?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:27","pubTimestamp":1780064838,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,步长制药报收于14.93元,较前一交易日上涨1.08%,最新总市值为157.45亿元。近日,山东步长制药股份有限公司发布《关于拟转让控股子公司股权及放弃优先受让权的进展公告》。同时,房克瑞拟将其持有的步长瀛玺商贸1.00%股权转让给陈立、1.00%股权转让给程诗淇,公司放弃优先受让权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638661687","title":"步长制药(603858)披露为控股子公司提供担保公告,5月28日股价下跌1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638661687","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638661687?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:35","pubTimestamp":1779960932,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘,步长制药报收于14.77元,较前一交易日下跌1.93%,最新总市值为155.76亿元。该股当日开盘15.06元,最高15.07元,最低14.73元,成交额达7261.2万元,换手率为0.46%。近日,山东步长制药股份有限公司发布《关于为公司控股子公司提供担保的公告》。截至公告日,公司及控股子公司对外担保总额为261,330.79万元,占公司最近一期经审计净资产的26.10%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800031720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638955653","title":"步长制药(603858)披露召开2025年年度股东会的通知,5月25日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638955653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638955653?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:44","pubTimestamp":1779720259,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘,步长制药报收于15.3元,较前一交易日上涨0.2%,最新总市值为161.35亿元。该股当日开盘15.28元,最高15.37元,最低15.16元,成交额达5601.66万元,换手率为0.35%。近日,山东步长制药股份有限公司发布《关于召开2025年年度股东会的通知》。公告显示,公司董事会宣布将于2026年6月26日召开2025年年度股东会,会议将采用现场投票与网络投票相结合的方式进行。股权登记日为2026年6月23日,A股股东可参会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375219","title":"每周股票复盘:步长制药(603858)控股子公司签署1200万流感疫苗许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375219","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375219?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:10","pubTimestamp":1779567018,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,步长制药报收于15.27元,较上周的15.81元下跌3.42%。本周关注点公司公告汇总:控股子公司签署人用季节性广谱流感疫苗知识产权合作协议,首付款1200万元。山东步长制药股份有限公司于2026年5月14日召开第五届董事会第四十八次会议,审议通过关于控股子公司住所变更的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636570308","title":"步长制药(603858)披露控股子公司拟签署知识产权合作协议的进展公告,5月19日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636570308","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636570308?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:48","pubTimestamp":1779202096,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,步长制药报收于15.67元,较前一交易日上涨0.58%,最新总市值为165.25亿元。近日,山东步长制药股份有限公司发布《关于控股子公司拟签署知识产权合作协议的进展公告》。公告显示,公司控股子公司浙江华派生物医药有限公司、浙江天元生物药业有限公司与合肥科医诺生物科技有限公司、南京科医诺生物科技有限公司就人用季节性广谱流感疫苗项目知识产权签署合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900044293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783522765381,"stockEarnings":[{"period":"1week","weight":0.0377},{"period":"1month","weight":0.0066},{"period":"3month","weight":-0.0928},{"period":"6month","weight":-0.0751},{"period":"1year","weight":-0.0661},{"period":"ytd","weight":-0.0313}],"compareEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":-0.0093},{"period":"3month","weight":-0.0012},{"period":"6month","weight":-0.0227},{"period":"1year","weight":0.1489},{"period":"ytd","weight":0.0054}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东步长制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"51168人(较上一季度减少2.91%)","perCapita":"20609股","listingDate":"2016-11-18","address":"山东省菏泽市牡丹区中华西路369号","registeredCapital":"105456万元","survey":" 山东步长制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是脑心通胶囊、稳心颗粒、丹红注射液、妇科用药、前列舒通胶囊、宣肺败毒颗粒、复方脑肽节苷脂注射液、复方曲肽注射液、谷红注射液、银杏蜜环口服溶液、生物药、流感病毒裂解疫苗、四价流感病毒裂解疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗。公司名列“2023年度中国中药企业TOP100排行榜”第四位。","listedPrice":55.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"步长制药,603858,步长制药股票,步长制药股票老虎,步长制药股票老虎国际,步长制药行情,步长制药股票行情,步长制药股价,步长制药股市,步长制药股票价格,步长制药股票交易,步长制药股票购买,步长制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}